Alejandra Palomino‐Antolín

Author

Also Known As

A. Palomino-Antolin, Alejandra Palomino-Antolin, Alejandra Palomino-Antolín, Alejandra Palomino‐Antolin, Alejandra Palomino‐Antolín, Fluorescence Imaging Group, Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, Spain.

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Universidad Autónoma de Madrid Hospital Universitario Santa Cristina Hospital Universitario de La Princesa Universidad Complutense de Madrid Research Institute Hospital 12 de Octubre

About

Alejandra Palomino‐Antolín is an author at Universidad Autónoma de Madrid specializing in cell signaling, medicine, and immune regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	267
2	Biochemistry	1	1	226
3	Cell Biology	1	1	41
4	Immunology	1	1	41
5	Metabolism	1	1	226

Alejandra Palomino‐Antolín

Publications

929

Citations

H-Index

Page 1

	Year	Citations
Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis‐mediated cell death Melania Guerrero‐Hue, Cristina García‐Caballero, Alejandra Palomino‐Antolín, The FASEB Journal	2019	257
Na+ controls hypoxic signalling by the mitochondrial respiratory chain Pablo Hernansanz‐Agustín, Carmen Choya-Foces, Susana Carregal‐Romero, Nature Mitochondrial Respiratory ChainMolecular PhysiologyBiochemistryMitochondrial FunctionMitochondrial Dynamic	2020	226
Multitarget‐Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H<sub>3</sub>R Antagonism for Neurodegenerative Diseases Óscar M. Bautista‐Aguilera, Stefanie Hagenow, Alejandra Palomino‐Antolín, Angewandte Chemie International Edition	2017	100
TLR4 pathway impairs synaptic number and cerebrovascular functions through astrocyte activation following traumatic brain injury Juliana M. Rosa, Víctor Farré‐Alins, María Cristina Ortega, British Journal of Pharmacology	2021	72
Early toll‐like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro‐inflammatory phenotype in rodent and human brain ischaemia models Esther Parada, Ana I. Casas, Alejandra Palomino‐Antolín, British Journal of Pharmacology	2019	57
New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H<sub>3</sub> Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition R.S. Malek, Raquel L. Arribas, Alejandra Palomino‐Antolín, Journal of Medicinal Chemistry	2019	42
Time‐dependent dual effect of NLRP3 inflammasome in brain ischaemia Alejandra Palomino‐Antolín, Paloma Narros‐Fernández, Víctor Farré‐Alins, British Journal of Pharmacology	2021	42
Melatonin Reduces NLRP3 Inflammasome Activation by Increasing α7 nAChR-Mediated Autophagic Flux Víctor Farré‐Alins, Paloma Narros‐Fernández, Alejandra Palomino‐Antolín, Antioxidants ImmunologyImmune RegulationCell DeathImmune SystemNeuroinflammation	2020	41
Synthesis and Pharmacological Evaluation of New <i>N</i>-Sulfonylureas as NLRP3 Inflammasome Inhibitors: Identification of a Hit Compound to Treat Gout Paloma Narros‐Fernández, Mourad Chioua, Sonia A. Petcu, Journal of Medicinal Chemistry	2022	24
Activation of NLRP3 Is Required for a Functional and Beneficial Microglia Response after Brain Trauma Ana Belén López-Rodríguez, Celine Decouty‐Pérez, Víctor Farré‐Alins, Pharmaceutics	2022	22

Page 1